Danaher High-growth markets — Sales increased by 15.1% to $2.03B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.9%, from $1.91B to $2.03B. Over 3 years (FY 2022 to FY 2025), High-growth markets — Sales shows relatively stable performance with a -3.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful penetration and demand capture in emerging economies, while a decrease may signal regional economic headwinds or competitive challenges in these growth-oriented areas.
This metric represents the total revenue generated from geographic regions identified as emerging or developing economie...
Peers in the life sciences and diagnostics sectors often report this as 'Emerging Markets Revenue' or 'Rest of World' sales, typically benchmarking against regional GDP growth rates.
dhr_segment_high_growth_markets_sales| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.93B | $1.93B | $1.93B | $1.93B | $1.80B | $1.80B | $1.80B | $1.80B | $1.54B | $1.70B | $1.72B | $1.91B | $1.54B | $1.70B | $1.76B | $2.03B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -6.7% | +0.0% | +0.0% | +0.0% | -14.5% | +10.3% | +1.6% | +11.1% | -19.7% | +10.4% | +3.8% | +15.1% |
| YoY Change | — | — | — | — | -6.7% | -6.7% | -6.7% | -6.7% | -14.5% | -5.7% | -4.2% | +6.5% | +0.0% | +0.1% | +2.2% | +5.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.